Active Litigation
LINX Reflux Device Lawsuit Facts
TorHoerman Law is investigating claims for the LINX Reflux Device Lawsuit.
LINX reflux device lawsuits allege that manufacturing defects allowed components of the implanted system to separate, shift, or lose the closed ring shape required for normal function.
The medical device is designed to treat gastroesophageal reflux disease (GERD) by placing a flexible band of titanium beads around the lower esophageal sphincter.
Magnetic force keeps the ring closed between swallows, which is intended to prevent stomach contents and acid reflux from moving back into the esophagus.
A mechanical failure can leave an open LINX device that no longer provides the pressure needed to control reflux.
Patients reported renewed heartburn, throat regurgitation, difficulty swallowing, chest discomfort, and severe pain after a LINX device implanted during laparoscopic surgery allegedly failed.
Some experienced symptoms that were different from, or more severe than, the problems present before surgery.
Recurrent acid exposure may irritate the esophagus, while broken or displaced components can create separate safety risks at the implant site.
Medical evaluations may reveal an open ring, shifted titanium beads, scar tissue, inflammation, or damage requiring removal of the device.
Device erosions present another serious complication.
Erosion occurs when part of the implant wears into or through esophageal tissue, which may cause pain, swallowing problems, bleeding, infection, or the need for additional surgery.
Lawsuits also describe patients who suffered injuries after the device migrated or separated and no longer remained properly positioned around the lower esophageal sphincter.
Current product liability cases examine whether recalled or nonconforming LINX devices departed from approved manufacturing specifications and whether inadequate quality controls allowed defective products to reach patients.
The existence of these claims does not establish that every LINX implant is defective or unsafe.
Each case depends on the implanted model and lot, imaging findings, operative records, explant evidence, and the medical connection between the alleged failure and the patient’s injuries.
LINX Device Complications and Reported Injuries
The LINX Reflux Management System is intended to reduce acid reflux by reinforcing the lower esophageal sphincter, but some patients have suffered complications after implantation.
At least 526 adverse events related to LINX devices had originally been identified in an earlier count of FDA MAUDE data.
A later analysis covering January 2011 through October 2021 identified 499 reports describing 918 patient-related adverse events and 101 device failures.
Dysphagia, painful swallowing, recurrent GERD, erosion, unexpected opening, bead separation, and migration were among the problems recorded in that analysis.
A device that opens, shifts, or erodes may no longer control reflux and can expose nearby tissue to increased acid reflux or direct internal injury.
Reported LINX injuries and complications include:
- Difficulty swallowing or painful swallowing
- Recurrent heartburn, regurgitation, or increased acid reflux
- Chest, abdominal, or swallowing-related pain
- Device erosion into esophageal tissue
- Device migration, unexpected opening, or bead separation
- Food impaction or esophageal obstruction
- Injury to the esophagus, stomach, spleen, or nearby tissue
- Surgical removal, revision surgery, or endoscopic dilation
Device erosion occurs when part of the implant wears into or through esophageal tissue, a process that may cause pain, chronic inflammation, or more difficult removal.
Patients who suffered complications have required diagnostic imaging, endoscopic dilation, removal surgery, or another anti-reflux procedure, depending on the nature and severity of the problem.
MAUDE reports document suspected events, not verified causation or incidence rates, because reports may be incomplete, duplicated, or submitted without data showing how many patients received the device.
Signs That a LINX Reflux Device May Have Failed
Patients diagnosed with gastroesophageal reflux disease may initially experience symptom relief after the LINX procedure, followed by the return or worsening of reflux-related symptoms.
A failed device may no longer maintain its intended position or closed ring structure around the lower esophageal sphincter.
Medical evaluation may be warranted when a patient develops any of the following signs:
- Recurrent heartburn or acid reflux
- Throat regurgitation or the return of stomach contents
- New or worsening difficulty swallowing
- Chest pain or severe pain near the implant site
- Food becoming stuck in the esophagus
- Imaging showing an open, separated, or displaced device
- Device migration or erosion into nearby tissue
- The need for dilation, removal surgery, or another corrective procedure
Some Patients Required LINX Removal or Revision Surgery
Some patients required surgical removal after the LINX device caused persistent dysphagia, recurrent reflux, erosion, migration, or mechanical separation.
Removal procedures may become necessary when dilation and other conservative measures fail to relieve symptoms.
Surgeons may also revise the original operation, repair damaged tissue, or perform another anti-reflux procedure to treat patients whose symptoms return after device failure.
Explant surgery can be more difficult when scar tissue or chronic inflammation has formed around the implant.
Patients may face additional anesthesia, hospital care, recovery time, and postoperative monitoring.
Lawsuits allege that some removal and revision procedures followed failures involving separated beads, broken wire links, or an open device.
Medical records documenting the reason for removal, operative findings, and the condition of the explanted device may become central evidence in a product liability claim.
LINX Recall and FDA Safety History
FDA approved the LINX Reflux Management System on March 22, 2012, for certain patients with gastroesophageal reflux disease documented through abnormal pH testing and persistent symptoms despite medical therapy.
Torax Medical, the original device manufacturer, later initiated a recall involving specific LINX models and production lots.
The regulatory history includes the following events:
- March 22, 2012: FDA granted premarket approval to the LINX Reflux Management System.
- April 20, 2018: Torax Medical initiated a recall covering certain 0.7-tesla and 1.5-tesla LINX models. FDA publicly posted the action on May 31, 2018.
- Class II classification: FDA classified the LINX device recall as Class II, a category used when exposure to a recalled product may cause temporary or medically reversible harm or when the probability of serious harm is remote.
- 9,131 affected devices: FDA records identify 9,131 LINX devices in commerce across the United States and several international markets.
- Reason for the recall: An out-of-specification condition could allow a bead component to separate from an adjacent wire link, leaving a discontinuous or open LINX device. The recall therefore concerned possible separation between magnetic bead components and their connecting wires, not a finding that magnets separated in every implanted device.
- November 4, 2020: FDA terminated the recall after the corrective action process was completed. Recall termination did not remove the original event from the agency’s safety history.
- Non-U.S. market withdrawal: Johnson & Johnson announced in 2025 that it would stop selling LINX in certain markets outside the United States following a review of market conditions, with reports identifying the end of March 2026 as the planned withdrawal date. The company described the action as a commercial decision rather than a new safety recall.
The international withdrawal should not be described as a global recall; LINX remains listed for use and sale in the United States.
Johnson & Johnson continues to maintain a current U.S. product page for the system, and FDA’s premarket approval record remains active with subsequent labeling supplements.
The 2018 recall and pending lawsuits do not establish that every LINX device is defective or unsafe, but they provide relevant evidence when an affected implant separates, opens, migrates, or requires surgical removal.
